P3 HEALTH PARTNERS INC (PIII) Stock Analyst Ratings
USA - NASDAQ:PIII - US7444132044 - Common Stock
6.1 USD
-0.3 (-4.69%)
ChartMill assigns a Buy % Consensus number of 78% to PIII. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 13.26. This target is 117.38% above the current price.
PIII was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about PIII.
In the previous month the buy percentage consensus was at a similar level.
PIII was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-17 | Lake Street | Maintains | Buy -> Buy |
| 2025-04-21 | Lake Street | Maintains | Buy -> Buy |
| 2024-11-20 | TD Cowen | Maintains | Hold -> Hold |
| 2024-04-01 | BTIG | Downgrade | Buy -> Neutral |
| 2024-03-14 | Lake Street | Maintains | Buy -> Buy |
| 2023-09-01 | BTIG | Initiate | Buy |
| 2023-06-30 | TD Cowen | Initiate | Market Perform |
| 2022-01-04 | William Blair | Initiate | Outperform |
P3 HEALTH PARTNERS INC / PIII FAQ
What do analysts expect the price target to be for P3 HEALTH PARTNERS INC (PIII)?
10 analysts have analysed PIII and the average price target is 13.26 USD. This implies a price increase of 117.38% is expected in the next year compared to the current price of 6.1.
Can you provide the consensus rating for P3 HEALTH PARTNERS INC stock?
The consensus rating for P3 HEALTH PARTNERS INC (PIII) is 78 / 100 . This indicates that analysts generally have a positive outlook on the stock.